Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
Grant support
NS 25743
NINDS NIH HHS - United States
PubMed
12023535
DOI
10.1124/jpet.301.3.1033
PII: S0022-3565(24)35705-2
Knihovny.cz E-resources
- MeSH
- Muscarinic Agonists metabolism MeSH
- Allosteric Regulation physiology MeSH
- Atropine pharmacology MeSH
- CHO Cells MeSH
- Kinetics MeSH
- Binding, Competitive drug effects physiology MeSH
- Cricetinae MeSH
- Humans MeSH
- Ligands MeSH
- N-Methylscopolamine metabolism MeSH
- Buffers MeSH
- Pyridines metabolism MeSH
- Receptor, Muscarinic M1 MeSH
- Receptors, Muscarinic metabolism MeSH
- Thiadiazoles metabolism MeSH
- Tritium MeSH
- Dose-Response Relationship, Drug MeSH
- Animals MeSH
- Check Tag
- Cricetinae MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, U.S. Gov't, P.H.S. MeSH
- Names of Substances
- Muscarinic Agonists MeSH
- Atropine MeSH
- Ligands MeSH
- N-Methylscopolamine MeSH
- Buffers MeSH
- Pyridines MeSH
- Receptor, Muscarinic M1 MeSH
- Receptors, Muscarinic MeSH
- Thiadiazoles MeSH
- Tritium MeSH
- xanomeline MeSH Browser
Xanomeline is a potent agonist that is functionally selective for muscarinic M(1) receptors. We have shown previously that a significant fraction of xanomeline binding to membranes of Chinese hamster ovary (CHO) cells expressing the M(1) receptors occurs in a wash-resistant manner and speculated that this persistent binding likely does not take place at the primary binding site on the receptor. In the present work we investigated in depth the pharmacological characteristics of this unique mode of xanomeline binding and the effects of this binding on the interaction of classical competitive ligands with the receptor in CHO cells that express the M(1) muscarinic receptor. Onset of persistent binding of xanomeline to the M(1) muscarinic receptor was fast and was only slightly hindered by atropine. Its dissociation was extremely slow, with a half-life of over 30 h. Although persistently bound xanomeline strongly inhibited binding of the classical antagonist N-methylscopolamine (NMS) to the receptor, there are multiple indications that this is not the result of competition at the same binding domain. Namely, wash-resistant binding of xanomeline only slightly slowed the rate of NMS association, but enhanced the rate of NMS dissociation. Moreover, preincubation with xanomeline followed by extensive washing brought about an apparent decrease in the number of NMS binding sites. Our findings are best interpreted in terms of allosteric interactions between xanomeline-persistent binding to the M(1) muscarinic receptor and competitive ligands bound to the classical receptor binding site.
References provided by Crossref.org
Fusion with Promiscuous Gα16 Subunit Reveals Signaling Bias at Muscarinic Receptors
Novel long-acting antagonists of muscarinic ACh receptors